Venlafaxine-related galactorrhea in an adolescent female : A case report

Copyright © 2022 Elsevier Inc. All rights reserved..

Hyperprolactinemia with galactorrhea is a well-documented adverse effect of some psychotropic medications. While advanced practice psychiatric nurses are likely familiar with hyperprolactinemia with galactorrhea as an adverse effect of antipsychotics, they may be less familiar with hyperprolactinemia with galactorrhea associated with antidepressants, an adverse effect that is far less common. Advanced practice psychiatric nurses must be able to identify hyperprolactinemia and galactorrhea in patients and must be able to evaluate and manage antidepressant-related hyperprolactinemia with galactorrhea. Thus, this case report describes hyperprolactinemia with galactorrhea in a teenage female prescribed venlafaxine for the treatment of major depressive disorder and posttraumatic stress disorder. To our knowledge, this is the first case report that describes galactorrhea related to a reuptake inhibitor (SNRI) in an adolescent.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:40

Enthalten in:

Archives of psychiatric nursing - 40(2022) vom: 01. Okt., Seite 106-108

Sprache:

Englisch

Beteiligte Personen:

Kameg, Brayden N [VerfasserIn]
Wilson, Rose [VerfasserIn]

Links:

Volltext

Themen:

7D7RX5A8MO
Adolescents
Antidepressive Agents
Case Reports
Journal Article
SNRIs
Venlafaxine Hydrochloride

Anmerkungen:

Date Completed 08.09.2022

Date Revised 23.09.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.apnu.2022.06.001

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM345814096